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A new device for the detection of lipid core-
containing plaques called a Catheter-based Lipi-
Scan™ Coronary Imaging System manufactured by
InfraReDx has received 510(k) clearance from the
U.S. Food and Drug Administration on 29 April 2008.
The LipiScan device uses near-infrared spec-
troscopy to identify lipid core-containing plaques of
interest in the coronary arteries in patients already
undergoing cardiac catheterization. Such plaques,
which cannot be detected by commonly-used tests
such as a treadmill examination or even coronary
angiography, are suspected to be the cause of most
sudden cardiac deaths and non-fatal heart attacks.
The InfraReDx LipiScan Imaging System uses
infrared imaging to detect lipid core-containing pla-
ques of interest and assess a patient’s coronary
artery lipid core burden index. The LipiScan Coro-
nary Imaging System is a catheter-based device that
uses laser light to detect how much fat and other
substances are contained in a plaque.
Near infrared (NIR) diffuse spectroscopy is
a technique based on the absorption of light in the NIR
spectrum, in a specific manner, by organic molecu-
les. NIR spectroscopy has demonstrated the ability
to identify plaques with lipid pools through blood [1].
The device works by placing a catheter equip-
ped with a fiber-optic laser into the artery. The de-
vice shines the near infrared light through the blo-
od to the artery wall and measures the light reflec-
ted back from it, a technique called spectroscopy.
The reflected wavelengths vary depending on how
much fat and other substances are in the plaque in
the illuminated portion of the wall.
The identification of the chemicals present is
based on the differential absorption of light in the
NIR spectrum by different molecules. An important
feature of near-infrared light is that it can penetra-
te tissue and can therefore identify a tissue despite
the presence of blood between the detector and the
target. This is an important advantage for imaging
within the human coronary artery.
The system consists of a laser light source, an
automated pullback and rotation device and a small
fiber-optic catheter. While the catheter is similar
in size and ease of use to an intravascular ultraso-
und catheter, the information it provides is quite dif-
ferent since it is based on an optical rather that an
ultrasonic signal (Fig. 1).
The NIR system obtains signals from patients
that are analyzed with algorithms validated by com-
parison to tissue histological findings in ex-vivo
coronary specimens. It is therefore possible to per-
form a pullback in a patient’s artery and provide an
image of the NIR signals which indicate the presen-
ce of lipids and other chemicals of interest. It is
expected that these images, which are called Intra-
vascular Chemograms™, will provide information for
interventional cardiologists to help in the care of
patients already undergoing cardiac catheterization
for coronary events. The identification of the che-
mical composition of coronary plaques is of value to
cardiologists in the selection of medical, stenting or
surgical therapy for coronary lesions. The device is
also expected to be of value to the pharmaceutical
industry as a means to assess the effect of novel anti-
atherosclerotic agents on lipid core plaque burden.
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The initial use of the InfraReDx device will be
for diagnosis, which will help in prevention of a se-
cond coronary event in the approximately 2 million
individuals world-wide who undergo a coronary in-
tervention each year.
Figure 1. Comparison of intravascular to near-infrared plaque imaging.
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